Venus Remedies Performance
Day's Low
Day's High
₹291.9Day's Price Range₹302.4552 Week's Low
52 Week's High
₹270.2552-Week Price Range₹427.9
| Returns % | |
| 1 Month Return | -5.92 % |
| 3 Month Return | -5.81 % |
| 1 Year Return | -22.15 % |
| Market Stats | |
| Previous Close | ₹291.70 |
| Open | ₹291.90 |
| Volume | 25.18K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹389.92Cr |
Venus Remedies Key Statistics
| P/E Ratio | 17.64 |
| PEG Ratio | -7.03 |
| Market Cap | ₹389.92 Cr |
| P/B Ratio | 0.86 |
| EPS | 21.31 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 6.18 |
Venus Remedies Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹389.92 Cr | 218.61% | 0.54 | ₹28 Cr | ₹601 Cr | |
| NA | ₹5,044.92 Cr | 65.41% | 0.52 | -₹71 Cr | ₹1,704 Cr | |
| NA | ₹2,549.73 Cr | 83.05% | 0.56 | -₹15 Cr | ₹180 Cr | |
| NA | ₹712.10 Cr | 199.49% | 0.91 | ₹55 Cr | ₹575 Cr | |
| BUY | ₹7,153.68 Cr | 1547.17% | 0.55 | ₹95 Cr | ₹819 Cr |
About Venus Remedies
Share Price: ₹296.80 per share as on 30 Jan, 2025 02:23 PM
Market Capitalisation: ₹389.92Cr as of today
Revenue: ₹167.45Cr as on September 2024 (Q3 24)
Net Profit: ₹3.51Cr as on September 2024 (Q3 24)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
| Organisation | Venus Remedies |
| Headquarters | Panchkula |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Venus Remedies Ltd
Venus Remedies Renew European GMP Certification - 20 Jan, 2025
Venus Remedies Ltd has successfully renewed its European Good Manufacturing Practices (GMP) certification, reaffirming its commitment to high-quality pharmaceutical products in the European market. This certification covers its manufacturing facility for key oncology and antibiotic formulations, maintaining a strong presence in Europe for over 15 years.Venus Remedies Anticipates Increased R&D Funding - 17 Jan, 2025
Saransh Chaudhary, President of Global Critical Care at Venus Remedies, expressed optimism for a significant rise in R&D funding in India, aiming to boost the country's pharmaceutical sector beyond the current 1% GDP investment.Venus Remedies Gains After GMP Certification in Moldova - 31 Dec, 2024
Venus Remedies Ltd shares surged after the company received Good Manufacturing Practice certification from Moldova, allowing expansion into Eastern Europe and ensuring access to reliable antibiotics.
Insights on Venus Remedies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 1.22 Cr → 3.51 Cr (in ₹), with an average increase of 65.2% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 110.2 Cr → 178.03 Cr (in ₹), with an average increase of 38.1% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 56.91% to 57.13% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 58.2% return, outperforming this stock by 80.4%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 151.6% return, outperforming this stock by 165.8%
NEGATIVE IMPACTPrice Dip
In the last 6 months, VENUSREM stock has moved down by -28.9%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 1.18% to 1.11% in Dec 2024 quarter
Venus Remedies Financials
Venus Remedies Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 41.76% | 0.00 | |
| Foreign Institutions | 1.11% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 57.13% | 0.38 | |
| Others | 0% |
Venus Remedies Key Indicators
Venus Remedies Valuation
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (17.64x)
January 29, 2025
Industry (51.91x)
January 29, 2025
Highest (21.70x)
December 28, 2023
Venus Remedies Earnings and Dividends
Venus Remedies Ltd Earnings Results
Venus Remedies Ltd’s net profit fell -64.69% since last year same period to ₹3.51Cr in the Q2 2024-2025. On a quarterly growth basis, Venus Remedies Ltd has generated 187.7% jump in its net profits since last 3-months.
Read More about Earnings Results
Venus Remedies Technicals Summary
Bearish
Neutral
Bullish
Venus Remedies Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Venus Remedies Ltd
What is Venus Remedies Ltd price today?
Venus Remedies Ltd share price today stands at ₹296.8, Open: ₹291.9, Previous Close: ₹291.7, High: ₹302.45, Low: ₹291.9, 52 Week High: ₹427.9, 52 Week Low: ₹270.25.
How to Buy Venus Remedies Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Venus Remedies Ltd shares
Is Venus Remedies Ltd listed on NSE?
Venus Remedies Ltd is listed on NSE
Is Venus Remedies Ltd listed on BSE?
Venus Remedies Ltd is listed on BSE
What are today's High and Low prices of Venus Remedies Ltd?
- Today's highest price of Venus Remedies Ltd is ₹302.45.
- Today's lowest price of Venus Remedies Ltd is ₹291.9.
What are today's traded volumes of Venus Remedies Ltd?
Today's traded volume of Venus Remedies Ltd(VENUSREM) is 25.18K.
What is today's market capitalisation of Venus Remedies Ltd?
Today's market capitalisation of Venus Remedies Ltd(VENUSREM) is ₹389.92Cr.
What is the 52 Week High and Low Range of Venus Remedies Ltd?
How much percentage Venus Remedies Ltd is down from its 52 Week High?
Venus Remedies Ltd (VENUSREM) share price is ₹296.8. It is down -30.64% from its 52 Week High price of ₹427.9
How much percentage Venus Remedies Ltd is up from its 52 Week low?
Venus Remedies Ltd (VENUSREM) share price is ₹296.8. It is up 9.82% from its 52 Week Low price of ₹270.25
What are the historical returns of Venus Remedies Ltd?
What is the PE ratio of Venus Remedies Ltd today?
PE Ratio of Venus Remedies Ltd is 17.64
PE ratio = Venus Remedies Ltd Market price per share / Venus Remedies Ltd Earnings per share